Cover Image
市場調查報告書

認知障礙:全球臨床實驗檢討

Cognitive Impairment Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 306656
出版日期 內容資訊 英文 106 Pages
訂單完成後即時交付
價格
Back to Top
認知障礙:全球臨床實驗檢討 Cognitive Impairment Global Clinical Trials Review, H1, 2014
出版日期: 2014年06月20日 內容資訊: 英文 106 Pages
簡介

本報告提供認知障礙相關的臨床研究最新趨勢分析,提供您疾病·治療方法概要,G7各國及E7(新興7國)的臨床實驗狀況,地區、Phase、階段別的進行狀況,並彙整有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

目錄

簡介

  • 認知障礙
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區前五名國家的臨床實驗數量
    • 歐洲前五名國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲的前五國的臨床實驗數量
    • 南美主要國家的臨床實驗數量

G7各國的臨床實驗數量:中樞神經系統臨床實驗的認知障礙臨床實驗數量比例

G7各國的臨床實驗數量:Phase別

G7各國的臨床實驗數量:各進展狀況

E7(新興7國)的臨床實驗數量:中樞神經系統的認知障礙臨床實驗數量比例

E7(新興7國)的臨床實驗數量:Phase別

E7(新興7國)的臨床實驗數量:各進展狀況

臨床實驗數量:Phase別

  • 進行中的臨床實驗:不同階段

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

未完成的臨床實驗

一定期間所採用的受驗者人數

贊助商類別的臨床實驗數量

有潛力的贊助商

有潛力的藥劑

臨床實驗簡介

  • 代表性企業臨床實驗概要
    • Pfizer Inc.
    • Novartis AG
    • Johnson & Johnson
    • Eli Lilly and Company
    • Merck & Co., Inc.
    • Eisai
    • AbbVie Inc.
    • 武田藥品
    • Shire Plc
    • GlaxoSmithKline plc
  • 有代表性的研究機關醫院臨床實驗概要
    • U.S. Department of Veterans Affairs
    • University of Washington
    • Charite - Universitatsmedizin Berlin
    • University Hospital Basel
    • National Institute on Aging
    • Vanderbilt University
    • University of Pennsylvania
    • Emory University
    • University Hospital, Angers
    • National Institute of Mental Health

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GDHC2204CTIDB

GlobalData's clinical trial report, "Cognitive Impairment Global Clinical Trials Review, H1, 2014" provides data on the Cognitive Impairment clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cognitive Impairment. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cognitive Impairment. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Cognitive Impairment
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Cognitive Impairment to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Cognitive Impairment to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Cognitive Impairment
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Cognitive Impairment Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Eisai Co., Ltd.
      • Clinical Trial Overview of Eisai Co., Ltd.
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Shire Plc
      • Clinical Trial Overview of Shire Plc
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
    • Clinical Trial Overview of Top Institutes / Government
      • U.S. Department of Veterans Affairs
      • Clinical Trial Overview of U.S. Department of Veterans Affairs
      • University of Washington
      • Clinical Trial Overview of University of Washington
      • Charite - Universitatsmedizin Berlin
      • Clinical Trial Overview of Charite - Universitatsmedizin Berlin
      • University Hospital Basel
      • Clinical Trial Overview of University Hospital Basel
      • National Institute on Aging
      • Clinical Trial Overview of National Institute on Aging
      • Vanderbilt University
      • Clinical Trial Overview of Vanderbilt University
      • University of Pennsylvania
      • Clinical Trial Overview of University of Pennsylvania
      • Emory University
      • Clinical Trial Overview of Emory University
      • University Hospital, Angers
      • Clinical Trial Overview of University Hospital, Angers
      • National Institute of Mental Health
      • Clinical Trial Overview of National Institute of Mental Health
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Region, 2014*
  • Cognitive Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cognitive Impairment Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Cognitive Impairment Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Cognitive Impairment Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Angers, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014*

List of Figures

  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Cognitive Impairment Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Cognitive Impairment Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Cognitive Impairment to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Cognitive Impairment Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Cognitive Impairment Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Cognitive Impairment Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Cognitive Impairment Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Cognitive Impairment Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top